26 /100
MEDIUM RISK
Score updated Jul 14, 2026

ZYME — Zymeworks Inc. Dilution Risk Tracker

Track ZYME dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ZYME — Get alerts when the score changes →

As of July 14, 2026, Zymeworks Inc. (ZYME) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Zymeworks Inc. has a market capitalization of $1.85B, 73.02M shares outstanding, 221 institutional holders tracked. Key dilution vectors include approximately 32 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ZYME.
🔔 Track ZYME — Get forecast alerts →

💹 Market Data

Market Cap$1.85B
Shares Outstanding73.02M
Float68.09M
Cash$461.05M
Debt$17.04M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 16.9% shares (2026Q1 vs prior)
221 institutional holders · 84.81M shares
#1 EcoR1 Capital, LLC 22.97M shares
#2 MORGAN STANLEY 9.06M shares
#3 PERCEPTIVE ADVISORS LLC 7.02M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.36M
Days to Cover6.2
% of Float6.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ZYME Shareholders

Zymeworks Inc. (ZYME) has a DilutionScore of 26/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for ZYME shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ZYME in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ZYME alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ZYME Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ZYME — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ZYME
📊 ZYME FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ZYME Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.